Por: Ars Technica Science November 21, 2022
Navigate Filter by topic Settings Front page layout Site theme - Nov 21, 2022 8:16 pm UTC / Pfizer CEO Albert Bourla talks during a press conference with the European Commission president after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021. Share this story Pfizer CEO Albert Bourla claimed at a news event last week that the company's... + full article
MarketWatch USA Business November 26, 2022
Rosenberg has been interviewed many times by Barron’s and has made some prescient calls. In late 2011, he compared (MSFT) favorably to (IBM), which had then drawn a big investment from (BRK.A). “Warren Buffett came pretty late to the IBM party,” he said. Microsoft is up... + más
Alphabet and Pfizer Stock Look Like Buys, Says This Longtime Market Maven | MarketWatch
Pfizer CEO reveals 2030 growth plan as company faces up to $18 billion revenue hit from generics | CNBC
CNBC USA Health November 02, 2022
Pfizer CEO Albert Bourla talks during a press conference with European Commission President after a visit to oversee the production of the Pfizer-BioNtech Covid-19 vaccine at the factory of US pharmaceutical company Pfizer, in Puurs, on April 23, 2021.John Thys AFP Getty Images... + más
Pfizer raises 2022 earnings guidance, beats third-quarter expectations | CNBC
Pfizer climbs on strong Q3 results, raised outlook | MarketWatch
CNBC USA Health November 01, 2022
In this articleVials containing the Pfizer/BioNtech vaccine against the coronavirus disease (COVID-19) are displayed before being used at a mobile vaccine clinic, in Valparaiso, Chile, January 3, 2022.Rodrigo Garrido Reuters on Tuesday raised its 2022 earnings guidance after... + más
New York Daily News USA Nation October 22, 2022
Get your shots while they’re on the house: Drug maker Pfizer said Friday that once the Federal government stops footing the bill for COVID-19 vaccines, the cost of a shot will rise to between $110 and $130 for adults. That pricing could start as early as 2023, though Pfizer... + más
Pfizer says it's eyeing a $110 to $130 list price for COVID-19 vaccine in U.S. | Fox Business
Moderna sues Pfizer over patents behind COVID-19 vaccine | The Advocate
The Advocate USA Crime October 10, 2022
vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine.Moderna said Friday that Pfizer and BioNTech’s vaccine Comirnaty infringes on patents Moderna filed... + más
Moderna is suing Pfizer over its coronavirus vaccine | The Verge
Moderna vs Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | Los Angeles Times
The Verge USA Health September 24, 2022
Moderna is suing Pfizer over its coronavirus vaccineModerna is suing Pfizer over its coronavirus vaccine / The company is filing patent infringement lawsuits against Pfizerp>span:first-child]:text-black text-blurple>By Aug 26, 2022, 12:37 PM UTC Share this story... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
About iurex | Privacy Policy | Disclaimer |